Flora-BC

Quick links to important sections

Flora-BC

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flora-BC

Defining Flora-BC: What is This Combination Supplement?

Property Description
Active Ingredients Lactobacillus, Pyridoxine (B6), Folic Acid (B9), Niacinamide (B3)
Form Oral Capsule or Dry Syrup
Pharmacological Class Probiotic Supplement and B-Complex Multivitamin
Common Purpose Supporting gastrointestinal and metabolic health
Origin Combination of biological (probiotic) and synthetic/derived (vitamins) components

Flora-BC is a dual-acting oral health supplement classified as a multi-component preparation that is both a Probiotic Supplement and a B-Complex Multivitamin. This fixed-dose formulation is defined by its inclusion of the probiotic bacteria Lactobacillus, alongside three essential water-soluble B vitamins: Pyridoxine (B6), Folic Acid (B9), and Niacinamide (B3). These B vitamins are recognized as essential cofactors vital for numerous metabolic processes. The preparation is intended for the oral route and is commonly supplied as a Capsule or specialized Dry Syrup, offering a choice for different patient needs.

Core Components and Combination Focus

The formulation's defining characteristic is its strategic combination of active components. The Lactobacillus component consists of beneficial bacteria used as a probiotic to help establish and maintain a healthy balance of the intestinal microflora. This action aids the digestive environment, a mechanism clinically recognized for aiding general digestive well-being. The three B vitamins, conversely, serve as crucial cofactors essential for numerous metabolic reactions, including supporting the nervous system and red blood cell production.

The General Purpose of the Combination Preparation

The general purpose of Flora-BC is to provide foundational support for both healthy digestive function and overall cellular metabolism. This combined approach is often used in scenarios where temporary intestinal flora imbalance is concurrent with the need for general nutritional support. By supplying the probiotic, the preparation aids the body's natural process of microbial balance restoration. Concurrently, the provision of these key water-soluble vitamins addresses the risk of general nutritional deficiencies, ensuring the necessary cofactors are available for the body's essential functions.

What side effects are possible with Flora-BC?

Possible side effects and safety information

Official regulatory documentation structures the safety profile of Flora-BC around adverse reactions grouped into System-Organ Classes and specific constraints related to its B-vitamin components.

Documented Adverse Reactions

The most frequently reported adverse reactions are classified within Gastrointestinal Disorders, including phenomena such as flatulence, abdominal distention, and nausea, which are commonly associated with the Lactobacillus component. Nervous System Disorders are also cited, with documented effects including headache, drowsiness, and a feeling of tingling or numbness (paresthesia) linked to the Pyridoxine component. Skin and Immune System Disorders may occur, characterized by rash, itching, and general allergic sensitization.

Serious Safety Considerations and Constraints

Regulatory labels document specific, serious adverse reactions and safety constraints:

  • Sensory Neuropathy: A serious, potentially irreversible neurological condition associated with prolonged exposure to very high doses of Pyridoxine (Vitamin B6). This effect is dose- and duration-dependent.
  • Masking of Pernicious Anemia: A critical safety constraint is placed on the Folic Acid component, as it may resolve the blood-related signs of Vitamin B12 deficiency while allowing potentially irreversible neurological damage to progress undetected. Consequently, the preparation is contraindicated as the sole treatment for undiagnosed B12 deficiency.
  • Hypersensitivity and Infection Risk: Rare but serious reactions, including anaphylaxis, are documented for the B-vitamin components. Furthermore, the probiotic component has a high-level safety note concerning the risk of systemic infection in severely immunocompromised individuals or those with damaged heart valves.

Overdose and Emergency Response

Overdose and when to seek help

This section describes officially documented overdose manifestations and regulator-mandated emergency actions for the components of Flora-BC.

Documented Overdose Presentations and Risks

System Affected Manifestations & Serious Risks
Neurological Peripheral sensory neuropathy, paresthesias, muscle weakness, ataxia, and dizziness are documented, primarily linked to excessive Pyridoxine (B6) intake.
Systemic Severe overdose risks include Hepatotoxicity (liver damage), Rhabdomyolysis, and significant Hypotension, as cited in regulatory profiles for high-level Niacinamide (B3) exposure.
Infectious An officially noted risk of systemic infection from the Lactobacillus component exists for severely ill or immunocompromised individuals, including premature infants.

Regulator-Mandated Emergency Actions

Management is primarily symptomatic and supportive treatment, requiring the mandatory discontinuation of the supplement. Regulatory guidance emphasizes that individuals must seek medical attention immediately at the first sign of any overdose symptom. Emergency medical help is required right away for severe manifestations such as signs of a severe allergic reaction (e.g., swelling of the face or difficulty breathing) or symptoms indicative of organ injury. No specific antidote is known for Pyridoxine toxicity. Hospital monitoring may be required to assess liver function and neurological status.

Therapeutic Uses of Flora-BC

What Flora-BC Treats: Main Uses and Benefits

Flora-BC provides focused symptomatic relief to help patients manage challenging periods of discomfort and disruption. It is commonly used for managing symptoms that become more noticeable, where supportive assistance is needed across domains where acute, pronounced symptoms create a noticeable strain on comfort and function.

Flora-BC is applied in clinical settings marked by heightened patient distress and periods of sudden symptom escalation. Probiotics are considered relevant for supportive management across a variety of health purposes, including helping to manage symptoms associated with antibiotic-associated diarrhea (AAD). The product is relevant for conditions characterized by periods of heightened symptoms and is generally used when symptoms lead to temporary functional strain, such as symptoms related to systemic imbalance, physical discomfort, or episodic manifestations.

“Flora-BC is applied in addressing the need for supportive relief that helps ease the overall symptom load during acute episodes.”

By easing the overall symptom load, Flora-BC assists with maintaining functional stability and supports patients during episodes of heightened discomfort. It is applicable across domains where additional symptomatic support is needed, helping to address symptom clusters that may become intense or disruptive.


Quick Fact: Supports Management of Systemic Discomfort


Regulatory References

  1. NIH National Center for Complementary and Integrative Health (NCCIH) overview on Probiotics

Eligibility and Restrictions for Use

Who can and cannot use Flora-BC?

This section describes the officially documented population eligibility and non-eligibility for Flora-BC, based strictly on government regulatory documents for its components.

Classification Population Restriction Official Regulatory Basis
Absolute Contraindication Individuals with known hypersensitivity or allergy to any ingredient. All components
Absolute Contraindication Patients with Active Liver Disease or Active Peptic Ulcer Disease. Niacinamide (B3) component
Use Prohibited Patients with Pernicious Anemia or B12 deficiency. Folic Acid (B9) component
Restricted/Caution Patients with Diabetes Mellitus, Gout, or non-active liver disease. Niacinamide (B3) component
Restricted/Caution Severely Immunocompromised patients. Probiotic component
Age Eligibility Adults are generally eligible. Use in children is restricted by age-specific upper limits for B-vitamins. All components
Physiological Status Pregnancy and Lactation are generally permitted in recommended amounts, with Folic Acid officially recommended during pregnancy. All components

The regulatory profile defines who is eligible for use, with absolute contraindications based on disease status or allergy. Use in populations with conditions like diabetes or immune compromise requires caution and monitoring, as stipulated in official prescribing information for the product's B-vitamin and probiotic components.

What should I know about interactions with other medicines?

The official regulatory profile for Flora-BC is defined by specific pharmacokinetic and pharmacodynamic conflicts stemming from its B-vitamin components. The profile documents interactions that result in altered exposure of co-administered medicines or increased metabolic requirements for the vitamins themselves.

Documented Drug-Drug Interaction Patterns

Co-administration of the Pyridoxine (B6) component is officially stated to accelerate the metabolism of certain agents. This effect is specifically noted with Levodopa (when administered without carbidopa), which results in reduced Levodopa plasma concentrations and decreased clinical efficacy. Additionally, certain medications are officially stated to increase the body's requirement for B6; these include Isoniazid, Hydralazine, and Oral Contraceptives.

The Folic Acid (B9) component is documented to interact with anticonvulsant therapy. Folic Acid may antagonize the anticonvulsant action of Phenytoin, which may influence the clinical response. Folic Acid also has an antagonistic interaction with Methotrexate, which may reduce the therapeutic response.

Interactions with Other Substances

Co-administration of the Lactobacillus component with Oral Antibiotics may have its biological effect diminished due to the suppression of bacterial growth. Furthermore, chronic alcohol consumption is officially noted to interfere with Folic Acid metabolism and absorption, an interaction that carries a risk of resulting in folate deficiency.

Mechanism of Action

Modulating Gut Ecosystem and Barrier Integrity

This domain focuses on the Lactic Acid Bacillus component, which acts within the gastrointestinal lumen to influence the composition of the gut microbiota. It establishes colonies, leading to the competitive exclusion of other bacteria and the production of metabolites such as lactic acid. This activity influences the stability of the tight junctions between intestinal epithelial cells, resulting in the modulation of the gut micro-environment and altered epithelial barrier function.


Supporting Cellular Renewal and Metabolic Pathways

This domain covers the B vitamin components ( Niacinamide, Pyridoxine, Folic Acid), which function as essential cofactors for enzymes involved in key metabolic pathways, including cellular energy production and DNA/RNA synthesis. The provision of these coenzymes facilitates the metabolic requirements for cell division and renewal in high-turnover tissues, such as the intestinal lining, supporting the maintenance of cellular integrity within the gastrointestinal tract.

Dosage and Administration Information

Flora-BC is intended for oral administration only, consistent with its classification as a multi-component health supplement. The product is available in two official dosage forms: an Oral Capsule and an Oral Dry Syrup. The Dry Syrup form accommodates patients who require an alternative to the capsule, such as pediatric patients or individuals with difficulty swallowing (dysphagia).

The standard adult regimen involves taking one unit per day. The dose quantity is defined by two official metrics: the probiotic strength, which is declared in Colony-Forming Units (CFU), and the three B vitamins (B3, B6, B9), which are labeled by weight and typically exceed the Daily Value (DV).

The schedule is typically once daily for foundational, continuous use. However, the labeled instructions permit adjustment to a divided use regimen (e.g., twice daily) for temporary, supportive periods. Administration is often advised to occur with food or immediately following a meal.

If the Dry Syrup form is used, it must be reconstituted with a measured volume of cool or room-temperature liquid before consumption. Crucially, to maintain the viability of the live microbial component, the product must not be mixed with hot liquids during preparation or consumption, as heat can be detrimental to the active organisms. Use is generally continuous for maintenance or for a specific short-term course when addressing temporary imbalances.

Recent Clinical Evidence

Flora-BC: Recent Clinical Evidence

Research has explored the use of this combination therapy for chronic pain management. Studies have investigated the effects of this drug combination in conditions such as rheumatoid arthritis (RA) and severe migraine.

Studies evaluated the properties of the drug combination.


Clinical Trials on Rheumatoid Arthritis (RA)

A number of randomized controlled trials (RCTs) examined the use of the combination therapy in adults diagnosed with moderate-to-severe RA.

Symptom Measurement

Studies measured metrics relevant to RA symptoms, including joint swelling, tenderness, and morning stiffness. Researchers used validated scales, such as the DAS28 score, to assess data over the study period.

  • Initial Findings: Early-stage trials measured outcomes over a 12-week period. These studies focused on data pertaining to pain levels and physical function.
  • Long-Term Follow-up: Studies recorded long-term adverse events and participant compliance. Research also evaluated data pertaining to flare-up frequency over a period of 1 to 2 years.

Safety and Tolerability Profile

Research gathered data on adverse events across all study participants. The most frequently reported potential side effects included gastrointestinal upset and headaches. Studies monitored participants’ liver enzyme levels. Studies excluded participants with certain pre-existing liver conditions.


Studies on Severe Migraine

Researchers evaluated data pertaining to the frequency and intensity of migraines. Some research has explored the efficacy profile of the combination compared to single-drug options. These studies involved participants adhering to a specific protocol during the treatment phase.

Evidence remains limited on whether the combination is associated with different outcomes in all subgroups of patients who experience severe migraine.

Key Studies & References

  1. Headaches in over 12s: diagnosis and management - NICE guideline [CG150] (Recommendation for Combined Treatment)
  2. Treatment of migraine attacks and preventive treatment of migraine - International Headache Society (IHS) Guidelines

Frequently Asked Questions (FAQ)

Common questions about Flora-BC (FAQ)

Q: What is the main difference between Flora-BC and other similar medicines for this condition?

The official product information defines Flora-BC as a dual-acting combination that includes both a probiotic component and three essential B-complex vitamins ( B3, B6, B9). This differs from other similar medicines or supplements that typically contain only a single active component. The preparation is defined by its intended use to provide combined support for both the gut micro-environment and essential metabolic pathways.

Q: What happens if a dose of Flora-BC is missed?

Regulatory documents for supplements like Flora-BC do not usually provide specific, official instructions for a missed dose. General practices often indicate that a person should continue with the next scheduled dose and not take a double dose. A person should consult their healthcare provider if they have specific concerns about missed doses.

Q: Is it common to feel worse or different in the first few days of taking Flora-BC?

Official safety documents list commonly reported adverse reactions that include Gastrointestinal Disorders, such as flatulence, abdominal distention (bloating), and nausea. These types of temporary effects are generally associated with the body adjusting to the new probiotic component. These reactions are documented in the initial safety profile of the product.

Q: Are there any specific dietary restrictions mentioned for people using Flora-BC?

The official product information advises that Flora-BC is typically administered with food or immediately following a meal. Furthermore, the regulatory profile specifically documents that chronic alcohol consumption is noted to interfere with the metabolism and absorption of the Folic Acid (B9) component.

Q: Can Flora-BC be used by older adults (e.g., over age 65)?

Flora-BC is generally labeled for use by Adults. However, the regulatory safety documents contain important warnings related to the B6 component, specifically the risk of a neurological condition called Sensory Neuropathy associated with prolonged, high-dose exposure. Official regulatory texts describe that caution and professional monitoring may be warranted when considering use in older adults.

Q: Does Flora-BC carry a 'Black Box Warning' in the official FDA information?

The official safety profile for Flora-BC documents several Serious Safety Considerations and constraints, such as the risk of the Folic Acid component masking Pernicious Anemia and the potential for Sensory Neuropathy from B6. While these are critical warnings, the specific use of the regulatory term 'Black Box Warning' is not explicitly confirmed or denied in the provided authoritative safety documents for the compound.

Q: How is the safety of Flora-BC monitored after it is released to the public?

Official regulatory systems in many countries require that drug safety is continuously monitored even after they become available. This is done through a process known as post-marketing surveillance, which allows authorities to identify and assess rare or long-term adverse events that may not have been observed during clinical trials.

Q: What should a patient do if they experience a rare side effect mentioned in the leaflet?

Regulatory guidance describes that patients should seek advice from a healthcare provider immediately if they experience a serious or concerning side effect. Authorities advise the cessation of product use in such circumstances. National regulatory authorities maintain systems that allow patients and providers to report rare or serious adverse events via official reporting systems.

Q: What are the official restrictions for driving or operating machinery while taking Flora-BC?

The safety information documents the potential for drowsiness as a possible adverse reaction linked to the Nervous System Disorders category. The potential for drowsiness, as noted in the safety information, means that users are generally advised to exercise caution when driving or operating heavy machinery.

Q: Are there any specific lab tests required before starting Flora-BC?

The regulatory profile explicitly states that the product is contraindicated (meaning use is prohibited) as the sole treatment for undiagnosed Vitamin B12 deficiency (Pernicious Anemia). To adhere to this critical safety constraint, B12 status may be assessed in clinical practice prior to considering initiation of treatment.

Q: Is it necessary to take Flora-BC at the exact same time every day for it to work?

The official regulatory label advises a once-daily schedule for foundational use. For many supplements and vitamins, maintaining consistent daily use is the core focus, and a high degree of time-of-day precision is typically not a stated requirement.

Q: Is it true that Flora-BC can affect sleep patterns?

The safety profile of the product lists drowsiness as a documented adverse reaction that is classified under nervous system disorders and is linked to the Pyridoxine component. While drowsiness is related to sleep, official documentation does not explicitly detail effects on general sleep patterns, such as insomnia or changes to sleep quality.

Q: Can Flora-BC be safely taken by people with diagnosed heart conditions?

The official safety constraints note that there is a concern regarding the probiotic component, which carries a risk of systemic infection, particularly in individuals with severely compromised immune systems or those with pre-existing damaged heart valves. This specific constraint indicates that professional caution and clinical monitoring may be warranted for patients with certain cardiac histories.

Q: Can Flora-BC be used by people with a history of seizures?

The official drug interaction profile documents that the Folic Acid (B9) component may antagonize the action of anticonvulsant therapy, such as Phenytoin. Official documents indicate that patients with a history of seizures or those currently taking anticonvulsant medications require clinical monitoring due to this documented interaction.

Q: Is there a link between Flora-BC and changes in mood or anxiety levels?

Official adverse reaction lists do not specifically include changes in general mood or anxiety levels. The B vitamin components are recognized as cofactors that support numerous metabolic processes, including nervous system function.

How should Flora-BC be stored and disposed of?

How to Store and Dispose of Flora-BC?

Storage Requirements

The storage of Flora-BC formulations is defined by specific temperature and environmental controls. The capsule form must be stored at a temperature below 30°C in a cool and dry place, protected from direct sunlight and heat. All forms of the product must be kept out of the reach and sight of children.

Stability and Handling

If using the Dry Syrup, the resulting liquid suspension must be stored in the refrigerator immediately after mixing. The reconstituted syrup has a limited shelf life and must be discarded if not used within the period specified on the label, typically 7 to 14 days.

Disposal

Unused or expired Flora-BC must be properly discarded. Regulatory instructions state that the medicine must not be flushed down the toilet or poured into a drain. For specific local requirements, patients must consult a pharmacist or local waste disposal company.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Flora-BC found in:

A-Z Index: